Chemotherapy-induced cardiomyopathy. - Wikidata - awgldk - TriplyDB

Chemotherapy-induced cardiomyopathy.

Chemotherapy-induced cardiomyopathy.

http://www.wikidata.org/entity/Q37867085

about

Identifying temporal patterns in patient disease trajectories using dynamic time warping: A population-based study.

P2860

Q52361012-0EBFBD92-A08C-4FA7-9E85-49FF27B9AD02

P2860

Chemotherapy-induced cardiomyopathy.

http://www.wikidata.org/entity/Q37867085

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Chemotherapy-induced cardiomyopathy.

@en

Chemotherapy-induced cardiomyopathy.

@nl

type

label

Chemotherapy-induced cardiomyopathy.

@en

Chemotherapy-induced cardiomyopathy.

@nl

prefLabel

Chemotherapy-induced cardiomyopathy.

@en

Chemotherapy-induced cardiomyopathy.

@nl

P1433

Q37867085-596F3C91-45BC-419A-ADDF-E8E5F26B0F04

P1476

Q37867085-D4888F79-AF9C-463B-816F-F35D83833D5F

P2093

Q37867085-0ED9D09E-9935-4BB8-BF68-957EC1B5C2A2

Q37867085-75D0EAB4-FF6C-4A32-AC5F-51A1A0185656

Q37867085-A8B04ED5-EF79-426B-AE50-719D9FDF8704

P2860

Q37867085-010640A0-F693-48F4-AFED-14118ABAEA6A

Q37867085-02454A74-9DC0-4435-89F6-0E443E73900A

Q37867085-0FBBC2EC-69BB-4736-96F5-6A2901408E34

Q37867085-1050BC02-7DC0-4903-87C5-A17CE501369B

Q37867085-10ECEC1E-E7F8-496F-B9C4-BA37D9607529

Q37867085-1CCF0233-5935-48C8-A1C4-30817F2EF2D8

Q37867085-1D1E094A-1B6B-41CE-8407-4E8FBC2E338E

Q37867085-20C96E25-4515-4CF2-8358-B983DB2B4F4A

Q37867085-20CA0F2F-AFDB-4857-9C29-91799BA0B2F2

Q37867085-23578B7A-038F-4BE0-8731-FE8A264720D1

P304

Q37867085-A314AABE-5EA9-4DBA-8DDB-5495D7658C82

P31

Q37867085-12F0F34E-C170-49D6-A9FE-43441FD21FD2

P356

Q37867085-3AE6E6B3-96CC-472B-9A04-0FCB7F3449CB

P433

Q37867085-46B3F4EB-7A88-49AB-98AF-C9FD620CEDCF

P478

Q37867085-36E5632B-FF19-47F8-A674-352D518159E5

P577

Q37867085-51958C89-4BD7-4762-A244-CC2368142065

P698

Q37867085-9A8A2318-6496-4C29-8A6C-34B9EDD42000

P921

Q37867085-30B6BB9D-5E82-411F-BCFA-14AF18A7B933

P356

P1433

Expert Review of Cardiovascular Therapy

P1476

Chemotherapy-induced cardiomyopathy.

@en

P2093

Jean-Bernard Durand

http://www.w3.org/2001/XMLSchema#string

Nasreen A Ilias-Khan

http://www.w3.org/2001/XMLSchema#string

Syed Wamique Yusuf

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

Cell signaling by receptor tyrosine kinases

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Cardiac dysfunction in the trastuzumab clinical trials experience

Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans

Risk factors for doxorubicin-induced congestive heart failure

Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma

Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report

P304

231-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERC.10.188

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21506294

http://www.w3.org/2001/XMLSchema#string

P921